Literature DB >> 9722688

Glycemic control and alveolar bone loss progression in type 2 diabetes.

G W Taylor1, B A Burt, M P Becker, R J Genco, M Shlossman.   

Abstract

This study tested the hypothesis that the risk for alveolar bone loss is greater, and bone loss progression more severe, for subjects with poorly controlled (PC) type 2 diabetes mellitus (type 2 DM) compared to those without type 2 DM or with better controlled (BC) type 2 DM. The PC group had glycosylated hemoglobin (HbA1) > or = 9%; the BC group had HbA1 < 9%. Data from the longitudinal study of the oral health of residents of the Gila River Indian Community were analyzed. Of the 359 subjects, aged 15 to 57 with less than 25% radiographic bone loss at baseline, 338 did not have type 2 DM, 14 were BC, and 7 were PC. Panoramic radiographs were used to assess interproximal bone level. Bone scores (scale 0-4) corresponding to bone loss of 0%, 1% to 24%, 25% to 49%, 50% to 74%, or > or = 75% were used to identify the worst bone score (WBS) in the dentition. Change in worst bone score at follow-up, the outcome, was specified on a 4-category ordinal scale as no change, or a 1-, 2-, 3-, or 4-category increase over baseline WBS (WBS1). Poorly controlled diabetes, age, calculus, time to follow-up examination, and WBS1 were statistically significant explanatory variables in ordinal logistic regression models. Poorly controlled type 2 DM was positively associated with greater risk for a change in bone score (compared to subjects without type 2 DM) when the covariates were included in the model. The cumulative odds ratio (COR) at each threshold of the ordered response was 11.4 (95% CI = 2.5, 53.3). When contrasted with subjects with BC type 2 DM, the COR for those in the PC group was 5.3 (95% CI = 0.8, 53.3). The COR for subjects with BC type 2 DM was 2.2 (95% CI = 0.7, 6.5), when contrasted to those without type 2 DM. These results suggest that poorer glycemic control leads to both an increased risk for alveolar bone loss and more severe progression over those without type 2 DM, and that there may be a gradient, with the risk for bone loss progression for those with better controlled type 2 DM intermediate to the other 2 groups.

Entities:  

Mesh:

Year:  1998        PMID: 9722688     DOI: 10.1902/annals.1998.3.1.30

Source DB:  PubMed          Journal:  Ann Periodontol        ISSN: 1553-0841


  33 in total

1.  Association between Diabetes Mellitus and Periodontal Diseases: A Survey of the Opinions of Dental Professionals.

Authors:  Emad AlShwaimi; Majdy Idrees; Zeina Berri; Haytham El-Sakka; Omar Kujan
Journal:  Med Princ Pract       Date:  2018-11-29       Impact factor: 1.927

2.  Non-surgical periodontal therapy with and without subgingival minocycline administration in patients with poorly controlled type II diabetes: a randomized controlled clinical trial.

Authors:  Shih-Jung Lin; Yu-Kang Tu; Shiow-Chwen Tsai; Shih-Ming Lai; Hsein-Kun Lu
Journal:  Clin Oral Investig       Date:  2011-03-18       Impact factor: 3.573

3.  Gingival crevicular fluid IL-6, tPA, PAI-2, albumin levels following initial periodontal treatment in chronic periodontitis patients with or without type 2 diabetes.

Authors:  Levent Kardeşler; Nurcan Buduneli; Sevki Çetinkalp; David Lappin; Denis F Kinane
Journal:  Inflamm Res       Date:  2010-09-17       Impact factor: 4.575

4.  Type 2 diabetes mellitus and 20 year incidence of periodontitis and tooth loss.

Authors:  Monik Jimenez; Frank B Hu; Miguel Marino; Yi Li; Kaumudi J Joshipura
Journal:  Diabetes Res Clin Pract       Date:  2012-10-03       Impact factor: 5.602

5.  Periodontal infection, impaired fasting glucose and impaired glucose tolerance: results from the Continuous National Health and Nutrition Examination Survey 2009-2010.

Authors:  Nidhi Arora; Panos N Papapanou; Michael Rosenbaum; David R Jacobs; Moïse Desvarieux; Ryan T Demmer
Journal:  J Clin Periodontol       Date:  2014-05-25       Impact factor: 8.728

6.  Oral bacterial communities in individuals with type 2 diabetes who live in southern Thailand.

Authors:  Kanokporn Kampoo; Rawee Teanpaisan; Ruth G Ledder; Andrew J McBain
Journal:  Appl Environ Microbiol       Date:  2013-11-15       Impact factor: 4.792

7.  Diabetes, periodontitis, and the subgingival microbiota.

Authors:  Edward J Ohlrich; Mary P Cullinan; Jonathan W Leichter
Journal:  J Oral Microbiol       Date:  2010-12-21       Impact factor: 5.474

8.  Bidirectional association between periodontal disease and diabetes mellitus: a systematic review and meta-analysis of cohort studies.

Authors:  Julia Stöhr; Janett Barbaresko; Manuela Neuenschwander; Sabrina Schlesinger
Journal:  Sci Rep       Date:  2021-07-01       Impact factor: 4.379

9.  The influence of type 1 and type 2 diabetes on periodontal disease progression: prospective results from the Study of Health in Pomerania (SHIP).

Authors:  Ryan T Demmer; Birte Holtfreter; Moïse Desvarieux; David R Jacobs; Wolfgang Kerner; Matthias Nauck; Henry Völzke; Thomas Kocher
Journal:  Diabetes Care       Date:  2012-08-01       Impact factor: 19.112

10.  Evaluation of Total Antioxidant Capacity of Saliva in Type 2 Diabetic Patients with and without Periodontal Disease: A Case-Control Study.

Authors:  Gowri Pendyala; Biju Thomas; Saurabh R Joshi
Journal:  N Am J Med Sci       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.